Keyphrases
Older Adults
52%
AIDS/HIV
44%
Early Life Stress
38%
COVID-19 Pandemic
32%
HIV+
31%
Executive Function
26%
Facial Emotion Recognition
26%
Amygdala
25%
Brain Volume
24%
Cerebral Perfusion
22%
Neuropsychiatric Symptoms
21%
Odds Ratio
19%
Confidence Interval
18%
COVID-19
18%
Neurobehavior
17%
Cortical Thickness
17%
Parkinson's Disease
17%
Healthcare Workers
17%
Human Immunodeficiency Virus Infection
16%
Cognitive Impairment
16%
Healthy Controls
16%
Substance Use
15%
Synergistic Effect
15%
Reaction Time Variability
15%
Cardiovascular Disease
15%
Emotional Faces
15%
Coping Mechanisms
15%
HIV-associated Neurocognitive Disorders
15%
People Living with HIV (PLHIV)
14%
Functional Magnetic Resonance Imaging
14%
HIV Patients
14%
Neurocognitive Function
13%
Emotion Recognition
12%
Combined Antiretroviral Therapy (cART)
12%
CD4 Nadir
12%
Cognitive Dysfunction
12%
Stress Exposure
11%
Generalized Anxiety Disorder
11%
Cognitive Functioning
10%
Highly Active Antiretroviral Therapy (HAART)
10%
Cerebral Hypoperfusion
10%
Telephone
10%
Posttraumatic Stress Disorder
10%
Ventral Striatum
10%
Reaction Time
10%
Intraindividual Variability
10%
Cognitive Function
10%
Visual Scanning
9%
Anger
9%
Young Adulthood
9%
Neuroscience
Human Immunodeficiency Virus
100%
Amygdala
32%
Cognitive Disorders
28%
Magnetic Resonance Imaging
25%
Arterial Spin Labeling
15%
Substance Abuse
15%
Parkinson's Disease
15%
HIV Associated Dementia
13%
Functional Magnetic Resonance Imaging
13%
Cognitive Function
12%
Frontal Lobe
12%
Adverse Effect
11%
Temporal Lobe
10%
Ventral Striatum
10%
CD4
9%
Longitudinal Study
9%
Functional Connectivity
9%
Cerebrovascular Disease
9%
Working Memory
9%
Gray Matter
8%
Central Nervous System
8%
Variable Number Tandem Repeat
7%
Alcohol Abuse
7%
Paclitaxel
7%
Hepatitis C
7%
Language Delay
7%
Neuropathy
7%
Antihypertensive Agent
7%
Decision-Making
7%
Parietal Lobe
7%
Executive Function
6%
Vascular Disease
6%
Generalized Anxiety Disorder
5%
Placebo
5%
Basal Ganglia
5%